심장 박동 관리 기기 시장 규모, 점유율, 성장 분석 : 제품별, 최종사용자별, 지역별 - 업계 예측(2026-2033년)

Cardiac Rhythm Management Devices Market size was valued at USD 20.92 Billion in 2024 and is poised to grow from USD 22.07 Billion in 2025 to USD 33.87 Billion by 2033, growing at a CAGR of 5.5% during the forecast period (2026-2033).

The increasing prevalence of cardiovascular disorders, coupled with a rising number of treatment procedures globally, is anticipated to significantly boost sales of cardiac rhythm management devices. Innovative advancements in technology, driven by heightened investment in cardiac research and development, are likely to enhance market prospects. The growing adoption of remote monitoring and telehealth practices will further stimulate demand for these devices. Additionally, increased healthcare spending and a focus on healthcare infrastructure improvements in emerging markets will create new opportunities for industry players. The trend towards minimally invasive cardiac procedures will also facilitate broader adoption. However, challenges such as battery limitations, device replacement needs, malfunction risks, and low awareness in emerging regions may hinder market growth potential.

Top-down and bottom-up approaches were used to estimate and validate the size of the Cardiac Rhythm Management Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Cardiac Rhythm Management Devices Market Segments Analysis

Global Cardiac Rhythm Management Devices Market is segmented by Product, End User, and region. Based on Product, the market is segmented into Pacemakers, and Defibrillators. Based on End User, the market is segmented into Hospitals & Clinics, Ambulatory Surgery Centers, and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Driver of the Cardiac Rhythm Management Devices Market

There has been a notable shift towards a preference for minimally invasive cardiac procedures among patients, which positively impacts the cardiac rhythm management devices sector. This growing inclination towards less invasive options aligns seamlessly with the advancements in cardiac rhythm management technologies. The ability to easily implant these devices through minimally invasive methods is anticipated to significantly enhance their demand over time. As patients increasingly seek out solutions that minimize discomfort and recovery time, the market for cardiac rhythm management devices is expected to benefit from this ongoing trend towards more patient-centric and efficient treatment options.

Restraints in the Cardiac Rhythm Management Devices Market

The cardiac rhythm management devices market faces significant challenges due to the risk of device failures and malfunctions, which can undermine patient confidence and lead to increased regulatory scrutiny. Such issues not only contribute to apprehension among patients regarding the reliability of these technologies but may also hinder future sales prospects. As regulatory bodies impose stricter guidelines and oversight in response to these concerns, the overall trust in cardiac rhythm management solutions may diminish, further impacting market growth and adoption rates. Addressing these vulnerabilities is crucial for sustaining momentum within the industry.

Market Trends of the Cardiac Rhythm Management Devices Market

The Cardiac Rhythm Management Devices market is increasingly focusing on enhancing patient outcomes for those with heart failure, driven by the capability of these devices to monitor critical physiological parameters, such as fluid accumulation. This innovative technology allows healthcare professionals to track cardiac health more effectively, leading to timely interventions that can prevent the progression of heart failure and reduce mortality rates. As awareness grows regarding the importance of early detection and management of heart-related issues, the demand for advanced monitoring solutions in cardiac care is expected to rise, thereby propelling market growth and driving innovations in device functionality and patient management strategies.

Table of Contents

Introduction

• Objectives of the Study
• Definitions
• Market Scope

Research Methodology

• Information Procurement
• Secondary & Primary Data Sources
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Market Overview Outlook
• Supply Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of Substitute Products
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Technology Analysis
• Pricing Analysis
• Value Chain Analysis
• Ecosystem of the Market
• Trade Analysis
• Supply chain Analysis
• Case study Analysis
• Patent Analysis
• Customer & Buying Criteria Analysis
• Regulatory Landscape
• Innovation Matrix
• Top Investment Analysis
• Key Success Factor
• Degree of Competition

Cardiac Rhythm Management Devices Market by Product

• Market Overview
• Pacemakers
  • Implantable
  • External
• Defibrillators
  • Implantable Cardioverter Defibrillators (ICD)
  • S-ICD
  • T-ICD
  • External Defibrillator
  • Manual External Defibrillator
  • Automatic External Defibrillator
  • Wearable Cardioverter Defibrillator
  • Cardiac Resynchronization Therapy (CRT)
  • CRT-Defibrillator
  • CRT-Pacemakers

Cardiac Rhythm Management Devices Market by End User

• Market Overview
• Hospitals & Clinics
• Ambulatory Surgery Centers
• Others

Cardiac Rhythm Management Devices Market Size by Region

• Market Overview
• North America
  • USA
  • Canada
• Europe
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America
  • Brazil
  • Rest of Latin America
• Middle East & Africa (MEA)
  • GCC Countries
  • South Africa
  • Rest of MEA

Competitive Landscape

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Activities in the Market
• Key Companies Market Share (%), 2025

Key Company Profiles

• Physio-Control, Inc. (Stryker) (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BIOTRONIK (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Schiller (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Koninklijke Philips N.V. (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Zoll Medical Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boston Scientific Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Progetti Srl (Italy)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• LivaNova Plc (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Impella (ABIOMED, US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AngioDynamics, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MicroPort Scientific Corporation (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Edwards Lifesciences Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Getinge AB (Sweden)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Synchrony Medical (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Osypka AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Inspire Medical Systems, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AtriCure, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Apex Medical (Taiwan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biotronik SE & Co. KG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• VivaSonic Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments